Company / Book Value per Share
Vaxcyte, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$19.733
FY2025
5-year range
$5.47 / $27.097
FY2021-FY2025
Trend
-27.2%
vs FY2024
Sector context
#29 of 209
Health Care
What the data says
Vaxcyte, Inc.'s book value per share of $19.733 is higher than 86% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 8 years, ranging from -$28.029 in FY2019 to $27.097 in FY2024.
Based on SEC 10-K filings.
$19.733 in FY2025 with a 5-year CAGR of +11.0%. Top quartile in the Health Care sector.
Improved from $12.768 to $19.733 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +10.3%
- 5-Year CAGR
- +11.0%
- 10-Year CAGR
- -
Sector benchmark
-89.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.0%, indicating consistent growth.
- In FY2025, book value per share decreased 27.2% year-over-year.
- Ranks #29 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.733 | -27.2% |
| FY2024 | $27.097 | +112.2% |
| FY2023 | $12.768 | -13.1% |
| FY2022 | $14.699 | +168.7% |
| FY2021 | $5.47 | -53.3% |
| FY2020 | $11.705 | +141.8% |
| FY2019 | -$28.029 | -76.2% |
| FY2018 | -$15.903 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026